CD44 and breast cancer: Interestingly, in a cellular assay with a lineage of multidrug-resistant BC cells, it was observed that the presence of exogenous brevican in the culture medium interfered with the formation of HA-CD44 complexes, which sensitized the cells against doxorubicin [141].